WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

3.02.26

Wilson Sonsini Advises Sense on Strategic Investment from Analog Devices
On January 27, 2026, Sense, a leader in grid edge intelligence, announced it has received a strategic investment from Analog Devices, Inc. (ADI), a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. This new investment enables further development of grid edge intelligence and management solutions for grid operators. Together, the companies will work with smart meter developers and others in the energy industry to accelerate the adoption of high-performance data and computation capabilities to enable a smarter grid. Wilson Sonsini Goodrich & Rosati advised Sense on the transaction.
Client Highlights

2.12.26

Wilson Sonsini Advises Delta40 on $20 Million Funding
On February 11, 2026, Delta40, an integrated venture studio and VC fund investing in and supporting founders on the frontlines of Africa’s most urgent challenges, announced $20 million in funding. The milestone marks Africa’s first institutional raise linking venture building and early-stage capital, merging investment with hands-on studio support from experienced operators to build and scale start-ups across the continent. Wilson Sonsini Goodrich & Rosati advised Delta40 on the transaction.

Delta40 initially launched its venture studio model in Kenya and has since expanded to Lagos, Nigeria, providing portfolio companies with direct, on-the-ground support as they scale across the continent. Delta40 pioneered a unique venture studio and fund model that combines early-stage capital with embedded product, fundraising, commercial, finance, legal, growth, and exit expertise. Through this model, Delta40 partners with founders from idea to scale across energy and mobility, agriculture, and fintech—with a goal to integrate AI across all sectors.
Client Highlights

10.02.25

Wilson Sonsini Advises BeSound on $6.8 Million Financing
On September 30, 2025, BLOCH Quantum Imaging Solutions, Inc. (dba BeSound), a pioneering healthcare technology company revolutionizing breast cancer detection, announced it has raised $6.8 million from investors, including Overwater Ventures, Kindred Ventures, Muse Capital, Lux Capital, Wisdom.VC, Retron VC, Mana Ventures, Pave Health Ventures, SSC Venture Partners, Hyperplane VC, and Tom Hale, the CEO of Oura. Wilson Sonsini Goodrich & Rosati advised BeSound on the transaction.
News Articles

4.04.24

Firm Supports Justice Climate Fund in Successful Bid for $1 Billion Funding Award
On April 4, 2024, the U.S. Environmental Protection Agency and Vice President Kamala Harris announced that Justice Climate Fund (JCF) was selected to receive approximately $1 billion in funding under the Clean Communities Investment Accelerator program. Wilson Sonsini is honored to have supported JCF in connection with this once-in-a-generation commitment to building enduring clean and green financing institutions that deliver transformational climate equity for families and communities across this nation.    
News Articles

11.27.23

Boston Magazine Honors Jen Fang and Elke Trilla in 2023 Top Lawyers List
On November 21, 2023, Boston Magazine published its third annual list of Top Lawyers, which highlights the top attorneys in a wide range of legal specialties in the region. This extensive guide was compiled after local lawyers were invited to nominate up to three peers within specific specialties. Boston Magazine reviewed the credentials based on the votes with an advisory board to make the final choices. Wilson Sonsini partner Jennifer Fang and associate Elke Trilla were recognized in the guide for the third consecutive year.
Newsletters

10.26.23

Sustainability and ESG Advisory Practice Update, October 2023
We are pleased to share the October 2023 issue of Wilson Sonsini's Sustainability and ESG Advisory Practice Update. Each issue combines news, key legal developments, and resources related to sustainability and environmental, social, and governance (ESG) matters relevant to public and private companies internationally.
News Articles

8.16.23

Elke Trilla Named Among Boston Business Journal’s 2023 “40 Under 40”
On August 16, 2023, Boston Business Journal announced this year’s “40 Under 40” honorees, a list containing young founders, attorneys, and CEOs at some of the region's biggest companies viewed as rising stars. Wilson Sonsini Boston associate Elke Trilla is named among the selected honorees for this year’s class.
Client Highlights

4.18.23

Wilson Sonsini Advises Spring Lane Capital on $31 Million Fundraise for Spring Free EV
On April 6, 2023, Spring Free EV, a financial technology company accelerating the adoption of electric vehicles (EVs) through innovative fintech products, announced the completion of a $31 million fundraise that includes a debt facility and a Series A equity investment led by Spring Lane Capital, a $400 million private equity firm focused on providing hybrid capital for sustainable solutions in the energy, food, water, waste, and transportation industries. The financing will enable Spring Free EV to double the number of EVs it has already put on the road by the end of 2023, with the expectation of scaling to tens of thousands of vehicles on the road by 2025. In addition, at full-scale operation, the company expects to cut the upfront costs of utilizing EVs by more than half the current amount.
News Articles

12.06.22

Three Corporate Lawyers Honored in Boston Magazine Top Lawyers List
On November 22, 2022, Boston Magazine published its list of Top Lawyers, which highlights the “best and brightest” of the region’s legal community. The list was curated after local lawyers were asked to nominate three peers within specific specialties. Boston Magazine reviewed the credentials based on the votes with an advisory board to make the final choices. Wilson Sonsini corporate partners Jennifer Fang and Mark Solakian were recognized for the second year in a row. Corporate associate Elke Trilla, who joined Wilson Sonsini in 2022, was also honored for the second year.
Client Highlights

9.26.22

Wilson Sonsini Advises RA Capital Management on Rivus Pharmaceuticals' $132 Million Series B
On September 22, 2022, Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by RA Capital Management with participation from Bain Capital Life Sciences, BB Biotech AG, and existing investors Longitude Capital, Medicxi, and RxCapital. Wilson Sonsini Goodrich & Rosati advised RA Capital in the transaction.
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.